Abstract
In this study, a detailed characterization of Monocarboxylic Acid Transporter-1 (Mct1) in cytoplasmic vesicles of cultured rat brain microvascular endothelial cells shows them to be a diverse population of endosomes intrinsic to the regulation of the transporter by a brief 25 to 30 minute exposure to the membrane permeant cAMP analog, 8Br-cAMP. The vesicles are heterogeneous in size, mobility, internal pH, and co-localize with discreet markers of particular types of endosomes including early endosomes, clathrin coated vesicles, caveolar vesicles, trans-golgi, and lysosomes. The vesicular localization of Mct1 was not dependent on its N or C termini, however, the size and pH of Mct1 vesicles was increased by deletion of either terminus demonstrating a role for the termini in vesicular trafficking of Mct1. Using a novel BCECF-AM based assay developed in this study, 8Br-cAMP was shown to decrease the pH of Mct1 vesicles after 25 minutes. This result and method were confirmed in experiments with a ratiometric pH-sensitive EGFP-mCherry dual tagged Mct1 construct. Overall, the results indicate that cAMP signaling reduces the functionality of Mct1 in cerebrovascular endothelial cells by facilitating its entry into a highly dynamic vesicular trafficking pathway that appears to lead to the transporter's trafficking to autophagosomes and lysosomes.
Introduction
Monocarboxylic acid transporter 1, Mct1, is a ubiquitous transmembrane protein that facilitates proton coupled symport of important cellular energy substrates such as lactate and other monocarboxylates across plasma membranes [1], [2]. This makes it essential for the normal energy metabolism of cells and gives it pathophysiological importance for diseases in which monocarboxylate metabolism is a component. While the basic mechanics of its transport function is well understood, limited progress has been made in understanding the acute cell-signaling dependent regulation of Mct1, however, elucidating such mechanisms will promote development of new treatments for diseases involving monocarboxylic acid transport. The focus of this work was to elucidate mechanisms of acute regulation of Mct1 function in brain capillary cells. In brain, Mct1 facilitates an intercellular transport of lactic acid from astrocytes to neurons which is required for learning and memory [3], and it has important roles in brain cancer that point to it as a therapeutic target [4], [5]. Both of these involve a significant microvascular component that would likely involve acute cell signaling dependent Mct1 regulation, but this has not been well investigated in brain. In the blood-brain barrier, Mct1 is the only mechanism to transport lactic acid from brain to blood giving it a role in brain diseases such as stroke and injury where the level and time-course of cerebral lactic acidosis is a key etiological component [6], [7], [8]. Mct1 has also been targeted in cerebrovascular endothelial cells as a potential facilitator of blood to brain drug delivery [9], [10]. Therefore, it is important to understand basic mechanisms that regulate Mct1 function in cerebrovascular endothelial cells since they present specific targets for therapeutic drug development to treat brain diseases ranging from learning and memory disorders to stroke and cancer, and could enhance delivery of pharmaceuticals to brain.
It was previously shown that the β-adrenergic pathway regulates Mct1 function in the rat brain capillary endothelial cell line (RBE4) by reducing plasma membrane levels of the transporter in a mechanism involving its cAMP-dependent vesicular trafficking [6], [8]. Microscopic analysis first showed a punctate immunostaining pattern for Mct1 in the cytoplasm of RBE4 cells suggesting its localization to cytoplasmic vesicles [7], while later work showed Mct1 puncta colocalizing with antibodies to clathrin, caveolin-1, EEA1, and Rab11, consistent with its presence in clathrin coated vesicles, caveolae, early endosomes, and recycling endosomes [8]. However, the immunostaining process can produce artifacts involving protein extraction and relocalization, making it necessary to compliment and confirm the previous work with studies using expression systems [11]. Because of the emerging role for Mct1 vesicles as a key component of the regulatory mechanism that controls the transporter's function, such work is needed to characterize them and their role in the regulation of Mct1 by cAMP.
To this end, the objectives of the present study were 1) To design and verify the utility of a fluorescent protein tagged Mct1 fusion protein as a valid marker for examining the vesicular dynamics of Mct1 in living RBE4 cells; 2) To characterize basic aspects of Mct1 vesicles and their dependence on the intracellular termini of the transporter; and 3) To evaluate cAMP dependent changes in the vesicular trafficking of the Mct1 fusion protein.
Materials and Methods
Cell culture
RBE4 cells, a gift of F. Roux [12], were cultured as described previously [6], [7], [8]. Briefly, cells were grown on collagen-coated polystyrene tissue culture dishes or collagen-coated number 1 coverslips in minimum essential medium alpha and Ham's F-10 nutrient (1∶1) with 10% fetal bovine serum, 1% antibiotic–antimycotic, 0.3 mg/ml geneticin, and 1.0 ng/ml basic fibroblast growth factor. Cells were trypsinized, replated between 3 and 8 hours prior to experimentation and used at subconfluency.
Cytochemistry
To visualize fusion protein expression in fixed RBE4 cells, cells were transfected with expression vectors as described below and fixed at room temperature in 3.7% formaldehyde/phosphate buffered saline (PBS), rinsed and mounted. In dual transfection-immunodetection experiments, transfected fixed cells were rinsed with PBS, permeabilized with 0.5% TritonX-100 for 2.5 minutes at room temperature, blocked with 1.5% goat serum and stained overnight at 4°C with an anti-Rab5 antibody (diluted 1∶1000, Cell Signaling) or an anti-syntaxin-6 antibody (diluted 1∶1000, Cell Signaling). Primary antibodies were detected with Alexafluor-488 conjugated secondary antibodies (diluted 1∶125, Molecular Probes). For immunodetection of Mct1, cells were rinsed in PBS, permeabilized at room temperature as described in the text, blocked with 1.5% goat serum, and stained overnight at 4°C with an anti-Mct1 antibody (diluted 1∶1000, Millipore MP1286). The Mct1 primary antibody was detected with Alexafluor-488 conjugated secondary antibody (diluted 1∶125, Molecular Probes). All slides were mounted in ProLong Gold Antifade Reagent (Molecular Probes).
Confocal and epifluorescence microscopy
Confocal images were taken on a Leica SPE or an Olympus FV1000 confocal microscope using 63 or 60X oil immersion objectives, respectively. The confocal aperture was set at 1 Airy Unit to optimize the confocality of the images and single planes from a basal region of the cells were acquired. Fluorophores were excited with the appropriate lasers, 488 or 561 or 543 nm, and fluorescence emission was filtered with the appropriate band pass filters (FV1000) or an acousto-optical tunable filter (SPE), and detected with a CCD camera (FV1000) or high sensitivity spectral detector (SPE) using the manufacturer's acquisition software. Epifluorescence video images were acquired with an Olympus IX50 microscope fitted with a 100 watt mercury arc lamp, a 100X oil immersion objective, appropriate narrow band pass filters, a Hamamatsu digital cooled IEEE139 CCD camera, and Imaging Workbench Ver. 5.2 Software (INDEC Systems, Inc.).
Intracellular pH imaging
Ratiometric intracellular pH Imaging was conducted as described previously [6], [7], [8]. Cells were cultured on glass coverslips and loaded in HEPES-Buffered Saline (HBS) with 1 µM BCECF-AM for 20 minutes, and rinsed with fresh HBS before imaging with the Olympus IX50 microscope described above.
Determination of the area, relative pH, and velocities of Mct1 vesicles
RBE4 cells were transfected with mCherry-Mct1 plasmids as described below and loaded with BCECF-AM as described above. Live cells were imaged using the Leica SPE confocal microscope. Eight-bit images for each color channel were acquired and mCherry-Mct1 images were digitally thresholded and processed using the Integrated Morphometry Analysis function of MetaMorph Image Analysis software version 7.7.4.0 (Molecular Devices) to produce regions of interest (ROI's) that corresponded to individual Mct1 vesicles (Figure S1). The area of the vesicles was calculated by the software. For pH measurements, the ROI's were superimposed on the corresponding raw BCECF images and the intensity of the average BCECF fluorescence was measured for each ROI (fvesicle). A single additional region of interest was hand drawn around the perimeter of each cell and the average BCECF fluorescence was measured (fcell). Each fvesicle was divided by the corresponding fcell to produce a ratio representing the pH of the vesicle relative to the pH of the entire cell. Our previous intracellular pH imaging work has shown the pH represented by fcell to be 7.42+/−0.02 [7]. To quantify the velocities of Mct1 vesicles, epifluorescence video micrographs like that shown in supplemental video 1 (Video S1) were analyzed using the Track Objects function of the MetaMorph Image Analysis software.
Molecular cloning and transfection
The rat Mct1 nucleotide coding sequence was RT-PCR amplified from RBE4 cell total RNA using the RETROScript reverse transcription kit (Ambion). PCR primers (polylinkers) containing EcoR1 (forward) and Sal1 (reverse) restriction sites were designed to amplify the full length Mct1 coding sequence from cDNA as follows: forward - 5′GCCGAATTCAAT GCCACCTGCGATTGGC; reverse - 5′CCCGTCGACTCAGACTGGGCTCTCCTC. The Mct1 C-terminus deletion PCR product was similarly amplified with the same forward primer and a reverse primer containing a Sal1 restriction site: 5′CCCGTCGACTCGATAATTGATGC CCAT. Mct1 PCR products were subcloned into the pmCherry-C1 vector (Clontech) using EcoR1 and Sal1 and the completed expression vectors were sequenced by SeqWright (Houston, TX). The Mct1 N-terminus deletion sequence, in a synthetic MiniGene (Integrated DNA Technologies), was subcloned into the full-length mCherry-Mct1 plasmid using EcoR1 and PpuM1. The dual tagged EGFP-mCherry-Mct1 construct was a modification of the full-length mCherry-Mct1vector produced by subcloning EGFP sequences that were PCR amplified from the pEGFP-C1 vector (Clontech) using Sac1 and EcoR1 polylinkers. Plasmids were transfected into RBE4 cells using the Qiagen Attractene Transfection Reagent and the manufacturer's protocol.
Reagents
All reagents, unless otherwise specified, were purchased from Sigma Aldrich (St. Louis).
Results
Design and verification of a Mct1 fusion protein as a marker of Mct1 vesicular dynamics
A mCherry-Mct1 expression vector was designed to produce a protein product that would link mCherry to the N terminus of Mct1 with no other modifications to the transporter. The full length rat Mct1 DNA sequence was RT-PCR amplified from RBE4 cells, subcloned into the pmCherry-C1 expression vector (Clontech) and sequenced. The expression product was then tested for its distribution, function, and expression level in transiently transfected RBE4 cells. Examination of individual planes from confocal micrographs of living RBE4 cells clearly showed mCherry-Mct1 in numerous prominent puncta of various sizes and shapes, on the plasma membrane of basal, mid, and apical levels, and in lamellipodia and filopodia of the cells (Figure 1A). To examine whether the expression construct produced a pattern of Mct1 expression consistent with the native pattern, micrographs from transfected cells were compared with those from non-transfected cells that were fixed and immunostained for Mct1 using previously published methods and variations in the fixation procedure. The pattern of staining was comparable with that in immunostained cells, however, the puncta in the immuostained cells showed subtle changes in morphology among samples fixed by different methods (Figure 1 B-D). This verified that the appearance of Mct1 in cytoplasmic puncta was not simply an artifact of the methodology used to visualize it and showed a native expression pattern for the fusion protein.
To further evaluate the fusion protein's pattern of expression we co-expressed it in RBE4 cells with markers for specific types of endosomes and imaged it in live cells. In these experiments, mCherry-Mct1 colocalized in puncta with GFP tagged clathrin, YFP tagged caveolin-1, and GFP tagged LAMP-1, consistent with previous results using immunocytochemistry [8]. We also found a similar result in mCherry-Mct1 expressing cells which were fixed and counter immunostained with antibodies to Rab5, or syntaxin-6 (Figure 2). The colocalization of mCherry-Mct1 with each of these markers confirmed the presence of Mct1 in different types of cytoplasmic vesicles as previously reported.
Next, to test whether the fusion protein was overexpressed, which can cause artifacts when examining vesicular trafficking, we expressed and visualized mCherry-Mct1 in live cells after titration of the expression vector over a range of concentrations. The expression pattern was not changed at titers higher than those used in the following studies, or when lowered to the detection limits of confocal microscopy. This result supported the conclusion that the fusion protein was not overexpressed (Figure S2).
To further evaluate this, we then expressed the fusion protein and measured its functionality in RBE4 cells using BCECF-AM imaging, which reports Mct1 transport function as an initial rate of cytoplasmic acidification in response to the application of extracellular lactate [6], [7], [13]. As an internal control, cells that expressed mCherry-Mct1 were paired within single fields of view with cells that expressed only native Mct1 and the measurement was compared among cells across a series of experiments. Demonstrating the functionality of mCherry-Mct1 as a lactic acid transporter, the initial rate of cytoplasmic acidification was increased by 13% in cells that transiently expressed the fusion protein (p = 0.002 in a paired t-test, N = 3 experiments, 10 cells per group).
Combined, the bright fluorescence of mCherry-Mct1, the similarity between its expression pattern in immunostains, its colocalization with markers of various types of endosomes, the stability of the fusion protein's expression pattern at a very low plasmid titration, the confirmation of its transport functionality, and the low level gain of function in cells that expressed the fusion protein, strongly suggested that mCherry-Mct1 was not overexpressed, trafficked similar to native Mct1, and therefore could be used as a useful marker to follow the vesicular trafficking of Mct1 in RBE4 cells.
Characteristics of Mct1 vesicles and their dependence on the intracellular termini of Mct1
Because the peptide sequence of Mct1 has a number of elements in the intracellular N and C-terminal domains that could facilitate its localization to vesicles (Figure 3A), we deleted the N terminus (XN) or C terminus (XC) from the full-length (FL) mCherry-Mct1 fusion construct and transiently expressed each in RBE4 cells to see whether the deletion constructs would traffic normally. The basic mCherry-Mct1 staining pattern was not obviously changed by deletion of either terminus when examined in confocal micrographs (Figure 3B). Moreover, when the C-terminal sequence of Mct1 was isolated and expressed as a mCherry fusion protein the fluorescent product did not localize to vesicles or the plasma membrane, but instead was expressed diffusely in the cytosol and excluded from punctate regions (Figure 3C). A similar construct with a scrambled C terminal amino acid sequence appeared the same (not shown). Thus, at first glance the cytoplasmic termini did not appear to be important for localizing Mct1 to cytoplasmic vesicles.
Epifluorescence video micrographs of RBE4 cells transiently expressing mCherry-Mct1 showed the Mct1 vesicles to be highly dynamic, heterogeneous in size and velocity, and interactive with one another and the plasma membrane (Video S1). In the videos, two groups of vesicles were apparent upon inspection; a small-fast, and a large-slow moving population. To characterize this, video images from several cells were intensity-thresholded to show regions of interest (ROI's) corresponding to clearly identifiable individual vesicles, the area of each ROI was calculated, the regions were labeled (Figure S1 and materials and methods), and the vesicles divided into a small and a large half (0.82+/−0.04 and 2.72+/−0.2 µm2, N = 51 vesicles per group, p<0.001). Object tracking analysis showed that the smaller vesicles moved nearly twice as fast as the larger vesicles (0.37+/−0.03 and 0.72+/−0.05 µm/s, p<0.001). Thus, two populations of Mct1 vesicles were discernible by size and velocity. Vesicles increase in size during trafficking through the endosome/lysosome system [14]. Consistent with this, measurements of the areas of Rab5 and Lamp-1 puncta in micrographs of RBE4 cells showed the ratio of the Lamp1/Rab5 areas to be 1.8 (n = 5 cells each with 472 Lamp-1 and 1,361 Rab5 positive vesicles p = 0.01). Therefore, the larger slower vesicles likely more closely resemble lysosomes and the smaller faster vesicles likely represent early endosomes or close intermediates in the endosome/lysosome system.
To characterize the possible role of the intracellular termini in determining the size of Mct1 vesicles, images from single confocal planes taken just above the base of the cell were thresholded and ROI's were generated for analysis of their area as described above. One way analysis of variance (ANOVA) showed the areas of the XC-mCherry-Mct1 and XN-mCherry-Mct1 ROI's to be statistically significantly larger than those generated with FL-mCherry-Mct1 (p<0.001). Histograms of the size distributions showed that deletion of the intracellular termini caused the smallest vesicles to disappear (Figure 4). Thus, the termini of Mct1 may have importance for determining the more subtle aspect of the transporters localization to different sized vesicles.
In a second approach aimed at exploring whether the termini of Mct1 might control sorting to different types of vesicles, we transiently transfected RBE4 cells with the XC, XN, or FL-mCherry-Mct1 constructs and counter stained with the intracellular pH indicator BCECF-AM. BCECF fluorescence was uneven in living RBE4 cells imaged at 100X, showing brighter staining in the nuclear region and numerous dark and bright puncta in the cytoplasm (Figure S3). Many, but not all of the mCherry-Mct1 vesicles perfectly co-localized with the dark puncta (Figure 5A). Therefore, we evaluated the confocal micrographs for colocalization of mCherry-Mct1 with the level of BCECF fluorescence. This was done by superimposing vesicular ROI's, generated with mCherry-Mct1, on images from the same planes visualized with BCECF. The average BCECF fluorescence intensity for each ROI (fvesicle) was then divided by the average BCECF intensity of the entire cell (fcell) to give an idea of its relative pH (see also materials and methods). Histograms of the relative pH of the vesicles were normally distributed around fcell with slightly acid-shifted peaks (Figure 5B). For comparison, each distribution was fit with the Gaussian equation and shown as curves in the figure. Deletion of the termini of Mct1 caused the distributions to move in an alkaline direction with the effect being most dramatic in the XN group. ANOVA showed the mean relative pH values among the three groups to be statistically significantly different from one another (p<0.001). Therefore, the intracellular termini of Mct1 appeared to play a role in determining the pH distribution of vesicles to which the transporter localizes.
Overall, the above experimentation showed the Mct1 vesicles to span a range of sizes, velocities, and pH values, and the distributions over these parameters depended on elements in the C and N terminus of the transporter.
Characterization of the effect of intracellular cAMP on Mct1 vesicles
To investigate the potential effect of cAMP on the vesicular trafficking of Mct1, we treated FL-mCherry-Mct1 expressing RBE4 cells with a membrane permeant cAMP analog and videotaped mCherry fluorescence in confocal planes near the base of the cells over a 50 minute period beginning with initial treatment. Figure 6A and supplemental video 2 (Video S2) show a typical RBE4 cell responding by rapidly detaching from neighboring cells, rounding up, and forming prominent clusters of Mct1 vesicles within large processes that developed and extended from the main body of the cell. During the response, the clustered vesicles appeared to become nearly stationary while a group of smaller vesicles in the center of the cell remained mobile. Throughout the response, Mct1 was clearly visible on the plasma membrane and was prominent in numerous filopodia. Thus, cAMP caused changes in RBE4 cell morphology and clustering of Mct1 vesicles.
We then repeated the experiment in figure 5 with the addition of an experimental group that was treated with the cAMP analog to evaluate cAMP dependent changes in the relative pH of the population of Mct1 vesicles. Treatment caused a marked broadening of the relative pH distributions, with a slight overall shift to more acidic values (Figure 6B). This shift was not due to a cAMP dependent change in the cytosolic fluorescence (fcell) since this parameter decreased slightly with cAMP and therefore would have contributed to underestimating the acid shift (data not shown). In unpaired t-tests, the mean relative pH values were statistically significantly shifted in an acidic direction by cAMP within the XC and XN groups from 0.88 to 0.79 (p<0.001), and 0.94 to 0.77 (p<0.001), respectively. Interestingly, the mean relative pH of vesicles visualized with FL mCherry-Mct1 did not shift appreciably with cAMP, moving only from 0.85 to 0.84 (p = 0.56), however, broadening of the range was most pronounced in this group. In each case the cAMP dependent change in the pH distribution appeared to include emergence of an acidic peak (indicated by arrows in Figure 6B). This result is consistent with cAMP changing the intracellular trafficking of Mct1, with some vesicles moving to more acidic compartments by a mechanism involving elements in the intracellular termini of the transporter.
Finally, to confirm the effect of cAMP on the pH of mCherry-Mct1 vesicles, we constructed a dual EGFP-mCherry tagged full length Mct1 expression construct, transiently expressed it in RBE4 cells, and evaluated acid dependent quenching of EGFP fluorescence as a ratio of the acid-insensitive mCherry fluorescence (green/red) [15], [16]. Because both fluorochromes were physically linked to Mct1 with 1∶1 stoichiometry, merged red-green images would be expected to produce a uniform yellow signal in regions of neutral pH and a predominantly red signal in more acidic regions. In transfected cells, EGFP-mCherry-Mct1 was present in cytoplasmic puncta, and on the plasma membrane as a yellow signal, however, a small group of red-only vesicles was also present in the cytoplasm, consistent with a population of more acidic endosomes which contained the transporter (Figure 7A). To verify the utility of the construct as a pH indicator, we then acidified the cytoplasm of RBE4 cells by incubating them in the proton ionophore nigericin at low pH/high K+ or in lactate. In these experiments, the green/red ratio was significantly diminished when the pH of the cytoplasm was lowered by either nigericin or lactate (Figure S4). This verified the utility of the construct as a pH indicator. Furthermore, verifying that the transporter sometimes localized to vesicles of lower pH, ratiometric images (green/red) showed large punctate voids in the cytoplasm which perfectly colocalized with the mCherry signal (Figure S4). Therefore, we proceeded to test the effect of treating RBE4 cells with the cAMP analog. After a 25 minute exposure, treated cells showed a decrease in the green/red ratio, consistent with an acid shift in the pH of the Mct1 vesicles (Figure 7B). The means of the ratios dropped dramatically and were statistically significantly different in one way ANOVA tests with control = 0.56+/−0.19 and cAMP = 0.26+/−0.05, p<0.001 (variances are given). The result was repeated in independent experiments showing a dose response for the cAMP analog. In addition, the presence of the selective PKA inhibitor, H89, had an alkalizing effect on Mct1 vesicles that was not affected by co-incubation with the cAMP analog. This confirmed a role for PKA in controlling the pH of Mct1 vesicles, as previously shown for the effect of cAMP in regulating Mct1 function (Figure 7C) [6]. Overall, these experiments confirmed our results with BCECF and supported the conclusion that cAMP causes Mct1 to traffic to acidic compartments.
Discussion
Basic characteristics of Mct1 vesicles
The major scientific objectives of this work were to provide a basic characterization of Mct1 vesicles in RBE4 brain microvascular endothelial cells, to elucidate how they are involved in the regulation of Mct1 function by cAMP, and to examine whether trafficking of Mct1 vesicles is dependent upon elements in the transporter's cytoplasmic N or C termini. This study confirmed that Mct1 vesicles are not byproducts of a particular immunostaining process, or an artifact of our fusion protein's expression. It also confirmed the heterogeneous nature of the Mct1 vesicles which colocalized with markers for caveolae, clathrin coated vesicles, early endosomes, trans-golgi, and lysosomes. Fluorescence video data showed the Mct1 vesicles to be highly mobile in the cell and identified a relationship between the size and velocity of the vesicles. The vesicles were also shown to span broad size and pH ranges as expected for transporters moving through the relatively alkaline secretory pathway to increasingly acidic compartments of various endosomal and degradation pathways [17], [18]. Combined, the results of these experiments showed the utility of our mCherry-Mct1 fusion protein for investigating the vesicular trafficking of Mct1, and pointed to a complex and heterogeneous population of cytoplasmic vesicles being involved in the cellular trafficking of Mct1 in RBE4 cells.
Role for a degradation pathway in the cAMP dependent regulation of Mct1
Previous work in RBE4 cells demonstrated that β-adrenergic signaling through adenylyl cyclase, cAMP, and protein kinase A, rapidly decreases the level of Mct1 on the plasma membrane [6], [8]. This appears to involve caveolae, and ultimately decreases the transport function of Mct1 [8]. The study presented here extends our understanding of this regulatory pathway by showing that cAMP stimulates trafficking of Mct1, and increases the level of transporter found within more acidic endosomes. These results were consistent with regulatory pathways for other membrane proteins including β2-adrenergic receptors and glutamate transporters which are degraded in response to adrenergic signaling [19], [20]. We think the identity of the endosomes in our studies is most likely to be autophagosomes or lysosomes since the dual tag was fused to the endofacial surface of Mct1 and would be expected to face the cytoplasm as it traffics. Thus, only cytoplasmic acidification around a vesicle, or entry of the entire protein, or its vesicle, into an acidic compartment could have decreased the green/red fluorescence ratio in punctate patterns that we observed [21]. Since cAMP did not acidify the cytoplasm in our experiments, the latter interpretations seem most likely. This does not rule out the possibility of proteolytic removal and degradation of the fluorescent tag of our fusion proteins being stimulated by cAMP, however, this would still point to degradation of Mct1 being an endpoint of cAMP signaling in RBE4 cells. Thus, a more complete picture of the cAMP dependent regulation of Mct1 appears to include lysosomal degradation of the transporter as an endpoint in the regulatory process. Therefore, based on the previous literature, a more complete picture of the regulation of Mct1 involves cAMP stimulating its removal from the plasma membrane through a process involving its trafficking to caveolae, delivery to an endosomal trafficking pathway, and subsequent entry of a population of the transporters into autophagosomes or lysosomes where they would be degraded [6], [8].
Role of its cytoplasmic termini in the vesicular trafficking and regulation of Mct1
An important aspect of this study was results implicating the intracellular termini of Mct1 in its vesicular trafficking and cAMP dependent regulation. In epithelial cells, Mct1 is targeted to particular membranes independent of particular sorting motifs in its intracellular regions, instead requiring CD147 as a chaperone to control its localization [22], [23], [24]. The reported irrelevance of endogenous signals in Mct1 for its trafficking is surprising given multiple putative protein-protein interaction and trafficking motifs in its intracellular termini (Figure 3A). Our result that the transporter remained in vesicles after deletion of its N or C termini, and that the isolated C-terminus did not localize to vesicles or the plasma membrane, was consistent with the studies in epithelium. However, our observation that deletion of either termini caused Mct1 vesicles to become larger and more alkaline provided evidence that the termini are involved in regulating Mct1 trafficking. Moreover, effects of cAMP were altered by deletion of the termini, pointing to a role for them in the cAMP dependent regulation of Mct1. These effects were most pronounced when the N-terminus was deleted, indicating that its hydrophobicity, previously demonstrated phosphorylation in brain at Y11 or T12 [25], or its type 1 WW ligand could be important determinants of Mct1 regulation by cAMP (Figure 3A). Future studies should be designed to evaluate this. It is also an interesting possibility that some of the effects on vesicular properties could be due to terminus-dependent changes in Mct1 functionality within the vesicular membrane, and this should be examined in future studies. To the best of our knowledge this report is the first to provide evidence of a trafficking or regulatory function for the intracellular termini of Mct1.
Justification of the vesicular pH imaging assay developed in this study
While BCECF-AM is generally used as a cytoplasmic pH indicator, its use to measure the relative pH of cytoplasmic vesicles was a novel application developed in this study. This raised the question whether it truly reflected vesicular pH, or random variations in BCECF fluorescence in vesicles that failed to incorporate the dye. We think the method reported vesicular pH for the following reasons: 1) BCECF-AM has been previously shown to label alkaline organelles such as nuclei and mitochondria [26], [27], [28], [29]. Brighter staining of nuclei and fine puncta that looked like mitochondria were clearly observed, showing that the dye could access cytoplasmic organelles in our experiments (Figure 5A and Figure S3). 2) Some vesicles that were positive for mCherry-Mct1 showed bright BCECF fluorescence and so were clearly capable of incorporating the dye. 3) The heterogeneity in the relative pH of Mct1 vesicles and the shape of their pH distribution was strikingly similar to that of epithelial cell endosomes measured previously with FITC-dextran (Figure 5B) [27]. 4) cAMP acidified Mct1 vesicles when assessed by BCECF fluorescence and independently using our dual tagged Mct1 construct. Therefore, while our results do not rule out the possibility that some of the dark BCECF puncta simply excluded the dye, the most likely explanation for the cAMP dependent decrease in BCECF fluorescence of Mct1 vesicles would not be that treatment somehow improved their ability to exclude the dye, but rather led to their acidification which quenched the fluorescence.
Importance of the vesicular trafficking of Mct1
Vesicular trafficking is well known to localize proteins to cellular microdomains where they are active, and so is an important mechanism controlling the function of membrane transporters, receptors, and channels [30], [31]. Vesicular trafficking is a particularly prominent feature in endothelial barriers where it provides protein sorting functions, facilitates trans-barrier movement of bulk fluids and solutes, and it is uniquely differentiated in brain to support cerebral homeostasis [32], [33]. However, despite its potential importance for understanding the normal physiology of Mct1 and in developing therapeutic targets for certain brain diseases, the regulation of Mct1 trafficking has largely gone unstudied in brain cells of any type. Cerebral microvascular endothelial cells in vivo are unique in many properties including the close juxtaposition of their luminal and abluminal membranes and high expression of tight junction proteins. Junctional proteins act as a scaffolding to localize various ion channels and transporters into microdomains, contributing to their regulation and overall cellular function, and so could be important for localizing Mct1 in brain microvessels [34]. While this will be important to investigate in future studies that more closely model the blood brain barrier in vivo, these structural attributes were not well modeled in our studies with isolated cultured RBE4 cells; rather, our work was designed to elucidate basic Mct1 regulatory and trafficking pathways occurring at a cellular level in the simplest cell system. Therefore, we believe the present study is more relevant as a model for the regulation of Mct1 during embryogenesis and in certain brain pathologies when endothelial cells become migratory; for example, during vascularization of damaged areas following stroke and brain injury, or during neovascularization of growing brain tumors [35], [36], [37]. Supporting this, Mct4, a close isoform of Mct1, was shown to associate with CD147 and β-integrin in a complex essential for epithelial cell migration, and inhibition of Mct1 blocked bovine aortic endothelial cell migration in a pathway involving hypoxia-inducible factor-1 signaling [37], [38]. Unpublished work from our lab has shown that the transport function of Mct1 and RBE4 cell migration are simultaneously blocked by either Mct1 inhibitors or agents that disrupt vesicular trafficking. This suggests regulation of Mct1 by a mechanism involving its vesicular trafficking may be critical for controlling brain endothelial cell migration, and therefore vascularization of brain tissue during development or pathology. As such, the elucidation of vesicular trafficking pathways that control Mct1 location and function in cultured brain microvascular endothelial cells presented here provides important information that could lead to specific targets for developing new therapeutic approaches for stroke, brain injury, and brain cancers, where changes in brain capillary cell migration and vascularization are key components of the etiological and healing processes.
Supporting Information
Acknowledgments
We thank Professor Mike Tamkun, Ph.D., Colorado State University Fort Collins, for his help with the DIC/confocal video imaging work, Professor Paul Chacon Ph.D. for his help with the statistical analysis, and undergraduate student Cale Soole for his work.
Funding Statement
This study was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, Grant 1R15NS062404-01A2. The authors have no conflicts of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Halestrap AP, Price NT (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 2: 281–99. [PMC free article] [PubMed] [Google Scholar]
- 2. Bröer S, Schneider HP, Bröer A, Rahman B, Hamprecht B, et al. (1998) Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH. Biochem J. 333: 167–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, et al. (2011) Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144: 810–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Froberg MK, Gerhart DZ, Enerson BE, Manivel C, Guzman-Paz M, et al. (2001) Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 12: 761–5. [DOI] [PubMed] [Google Scholar]
- 5. Miranda-Gonçalves V, Honavar M, Pinheiro C, Martinho O, Pires MM, et al. (2013) Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro Oncol 15: 172–88. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Smith JP, Drewes LR (2006) Modulation of monocarboxylic acid transporter-1 kinetic function by the cAMP signaling pathway in rat brain endothelial cells. J Biol Chem 281: 2053–2060. [DOI] [PubMed] [Google Scholar]
- 7. Uhernik AL, Tucker C, Smith JP (2011) Control of MCT1 function in cerebrovascular endothelial cells by intracellular pH. Brain Res 1376: 10–22. [DOI] [PubMed] [Google Scholar]
- 8. Smith JP, Uhernik AL, Li L, Liu Z, Drewes LR (2012) Regulation of Mct1 by cAMP-dependent internalization in rat brain endothelial cells. Brain Res 1480: 1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Vijay N, Morris ME (2013) Role of Monocarboxylate Transporters in Drug Delivery to the Brain. Curr Pharm Des. Jun 19. [Epub ahead of print]. [DOI] [PMC free article] [PubMed]
- 10. Urquhart BL, Kim RB (2009) Blood-brain barrier transporters and response to CNS-active drugs. Eur J Clin Pharmacol 65: 1063–70. [DOI] [PubMed] [Google Scholar]
- 11. Schnell U, Dijk F, Sjollema KA, Giepmans BNG (2012) Immunolabeling artifacts and the need for live-cell imaging. Nature Methods 9: 152–158. [DOI] [PubMed] [Google Scholar]
- 12. Roux F, Durieu-Trautmann O, Chaverot N, Claire M, Mailly P, et al. (1994) Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol 159: 101–13. [DOI] [PubMed] [Google Scholar]
- 13. Carpenter L, Halestrap AP (1994) The kinetics, substrate and inhibitor specificity of the lactate transporter of Ehrlich-Lettre tumour cells studied with the intracellular pH indicator BCECF. Biochem J 304: 751–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Huotari J, Helenius A (2011) Endosome Maturation. EMBO J 30: 3481–3500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Kneen M, Farinas J, Li Y, Verkman AS (1998) Green fluorescent protein as a noninvasive intracellular pH indicator. Biophys J 74: 1591–1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Ashby MC, Ibaraki K, Henley JM (2004) It's green outside: tracking cell surface proteins with pH-sensitive GFP. Trends Neurosci 27: 257–61. [DOI] [PubMed] [Google Scholar]
- 17. Brett CL, Tukaye DN, Mukherjee S, Rao R (2005) The yeast endosomal Na+K+/H+ exchanger Nhx1 regulates cellular pH to control vesicle trafficking. Mol Biol Cell 16: 1396–405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Mellman I (1992) The importance of being acid: the role of acidification in intracellular membrane traffic. J Exp Biol 172: 39–45. [DOI] [PubMed] [Google Scholar]
- 19. Koryakina Y, Jones SM, Cornett LE, Seely K, Brents L, et al. (2012) Effects of the β-agonist, isoprenaline, on the down-regulation, functional responsiveness and trafficking of β2-adrenergic receptors with N-terminal polymorphisms. Cell Biol Int 6: 1171–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Yang L, Wang S, Sung B, Lim G, Mao J (2008) Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation. J Biol Chem 283: 21703–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Kraft C, Martens S (2012) Mechanisms and regulation of autophagosome formation. Curr Opin Cell Biol 24: 496–501. [DOI] [PubMed] [Google Scholar]
- 22. Castorino JJ, Deborde S, Deora A, Schreiner R, Gallagher-Colombo SM, et al. (2011) Basolateral sorting signals regulating tissue-specific polarity of heteromeric monocarboxylate transporters in epithelia. Traffic 12: 483–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Deora AA, Philp N, Hu J, Bok D, Rodriguez-Boulan E (2005) Mechanisms regulating tissue-specific polarity of monocarboxylate transporters and their chaperone CD147 in kidney and retinal epithelia. Proc Natl Acad Sci USA 102: 16245–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Philp NJ, Ochrietor JD, Rudoy C, Muramatsu T, Linser PJ (2003) Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci 44: 1305–1311. [DOI] [PubMed] [Google Scholar]
- 25. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, et al. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143: 1174–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Straubinger RM, Papahadjopoulos D, Hong KL (1990) Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry 29: 4929–39. [DOI] [PubMed] [Google Scholar]
- 27. Shi LB, Fushimi K, Bae HR, Verkman AS (1991) Heterogeneity in ATP-dependent acidification in endocytic vesicles from kidney proximal tubule. Measurement of pH in individual endocytic vesicles in a cell-free system. Biophys J 59: 1208–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Thomas JA, Buchsbaum RN, Zimniak A, Racker E (1979) Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18: 2210–8. [DOI] [PubMed] [Google Scholar]
- 29. Llopis J, McCaffery JM, Miyawaki A, Farquhar MG, Tsien RY (1998) Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc Natl Acad Sci USA 95: 6803–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Rodriguez-Boulan E, Kreitzer G, Müsch A (2005) Organization of vesicular trafficking in epithelia. Nat Rev Mol Cell Biol 6: 233–47. [DOI] [PubMed] [Google Scholar]
- 31. Frank PG, Woodman SE, Park DS, Lisanti MP (2003) Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol 23: 1161–8. [DOI] [PubMed] [Google Scholar]
- 32. Candela P, Gosselet F, Miller F, Buee-Scherrer V, Torpier G, et al. (2008) Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Endothelium 15: 254–64. [DOI] [PubMed] [Google Scholar]
- 33. Virgintino D, Robertson D, Errede M, Benagiano V, Tauer U, et al. (2002) Expression of caveolin-1 in human brain microvessels. Neuroscience 115: 145–52. [DOI] [PubMed] [Google Scholar]
- 34. Hervé JC, Bourmeyster N, Sarrouilhe D, Duffy HS (2007) Gap junctional complexes: from partners to functions. Prog Biophys Mol Biol 94: 29–65. [DOI] [PubMed] [Google Scholar]
- 35. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, et al. (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156: 965–976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Liman TG, Endres M (2012) New vessels after stroke: postischemic neovascularization and regeneration. Cerebrovasc Dis 33: 492–9. [DOI] [PubMed] [Google Scholar]
- 37. Sonveaux P, Copetti T, De Saedeleer CJ, Végran F, Verrax J, et al. (2012) Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis. PLoS One 7: e33418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Gallagher SM, Castorino JJ, Philp NJ (2009) Interaction of monocarboxylate transporter 4 with beta1-integrin and its role in cell migration. Am J Physiol Cell Physiol 296: C414–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.